RENAISSANCE TECHNOLOGIES LLC

Position in EYPT — EyePoint, Inc.

CIK 1037389 NEW YORK, NY

Position in EYPT

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,511,997

+$386,565 QoQ

Shares Held

117,300

+90.4% QoQ

Ownership

0.140%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. EYPT ranks #161 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,511,997	117,300	+90.4%	Shares	Sole	2026-05-14
2025-12-31	$1,125,432	61,600	+66.5%	Shares	Sole	2026-02-12
2025-06-30	$348,170	37,000	-68.5%	Shares	Sole	2025-08-13
2025-03-31	$635,766	117,300	-14.7%	Shares	Sole	2025-05-14
2024-12-31	$1,024,375	137,500	-26.6%	Shares	Sole	2025-02-13
2024-09-30	$1,497,621	187,437	+22.7%	Shares	Sole	2024-11-13
2024-06-30	$1,329,360	152,800	+112.5%	Shares	Sole	2024-08-09
2024-03-31	$1,486,173	71,900	+366.9%	Shares	Sole	2024-05-13
2023-06-30	$133,980	15,400	-78.4%	Shares	Sole	2023-08-11
2023-03-31	$209,622	71,300	+197.1%	Shares	Sole	2023-05-12
2022-12-31	$84,000	24,000	-68.0%	Shares	Sole	2023-02-13
2021-03-31	$762,508	75,050	+322.6%	Shares	Sole	2021-05-13
2020-12-31	$116,860	17,760	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.